UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported) May 28, 2021

ARES CAPITAL CORPORATION

(Exact Name of Registrant as Specified in Charter)

Registrant’s telephone number, including area code (212) 750-7300

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

On May 28, 2021, Ares Capital Corporation (the “Company”) issued an additional $500 million aggregate principal amount of its 3.250% notes due 2025 (the “New 2025 Notes”) pursuant to a Purchase Agreement, dated May 26, 2021 (the “Purchase Agreement”), among the Company, Ares Capital Management LLC, Ares Operations LLC and J.P. Morgan Securities LLC. The New 2025 Notes were issued as additional notes under the Indenture, dated October 21, 2010 (the “Base Indenture”), between the Company and U.S. Bank National Association (the “Trustee”), as supplemented by the Eleventh Supplemental Indenture, dated January 15, 2020 (the “Eleventh Supplemental Indenture,” and together with the Base Indenture, the “Indenture”), pursuant to which, on January 15, 2020, the Company issued $750 million aggregate principal amount of its 3.250% notes due 2025 (the “Existing 2025 Notes”). The New 2025 Notes are being treated as a single series with the Existing 2025 Notes under the Indenture and have the same terms as the Existing 2025 Notes. The New 2025 Notes have the same CUSIP number and are fungible and rank equally with the Existing 2025 Notes.

The New 2025 Notes were issued at a premium of 104.745% of their principal amount, resulting in estimated net proceeds, after estimated offering expenses, of approximately $519.8 million. Aggregate estimated offering expenses in connection with the offering of the New 2025 Notes, including the underwriting discount of $2.5 million, were approximately $3.9 million. The Company expects to use the net proceeds of this offering to repay certain outstanding indebtedness under its credit facilities. The Company may reborrow under its credit facilities for general corporate purposes, which include investing in portfolio companies in accordance with its investment objective.

The New 2025 Notes will mature on July 15, 2025 and may be redeemed in whole or in part at the Company’s option at any time at the redemption prices set forth in the Eleventh Supplemental Indenture. The New 2025 Notes bear interest at a rate of 3.250% per year payable semiannually on January 15 and July 15 of each year. The New 2025 Notes are direct senior unsecured obligations of the Company.

The New 2025 Notes were offered and sold pursuant to the Registration Statement on Form N-2 (File No. 333- 248831), the preliminary prospectus supplement filed with the Securities and Exchange Commission (the “SEC”) on May 26, 2021 and the pricing term sheet filed with the SEC on May 26, 2021.

The foregoing description of the New 2025 Notes does not purport to be complete and is qualified in its entirety by reference to the full text of the Eleventh Supplemental Indenture and the accompanying Form of 3.250% Notes due 2025, filed as Exhibits 4.1 and 4.2, respectively, to the Company’s Current Report on Form 8-K filed with the SEC on January 15, 2020 and incorporated by reference herein. 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.